Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean O'Neill

Showing results (71-80 of 111) with videos related to

Pageof 12
Sort By:
Health and Quality of Life Outcomes|January 11, 2022
Development and measurement properties of the AxEL (attitude toward education and advice for low-back-pain) questionnaireEdel T O'Hagan, Ian W Skinner, Matthew D Jones, et al.
Biomacromolecules|July 30, 2019
Thermoresponsive Protein-Engineered Coiled-Coil Hydrogel for Sustained Small Molecule ReleaseLindsay K Hill, Michael Meleties, Priya Katyal, et al.
Development (Cambridge, England)|October 10, 2015
Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in miceScott E Williams, Idoia Garcia, Andrew J Crowther, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Internal Medicine Journal|May 14, 2022
Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritisSamuel L Whittle, Vanessa Glennon, Renea V Johnston, et al.
BMJ Open|December 10, 2024
Integrating accelerometry, GPS, GIS and molecular data to investigate mechanistic pathways of the urban environmental exposome and cognitive outcomes in older adults: a longitudinal study protocolRuth F Hunter, Claire Cleland, Mike Trott, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
The Lancet. Rheumatology|January 23, 2024
Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort studyDiane Apostolopoulos, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Arthritis Care & Research|July 21, 2019
Patient and Caregiver Priorities for Medication Adherence in Gout, Osteoporosis, and Rheumatoid Arthritis: Nominal Group TechniqueAyano Kelly, Kathleen Tymms, Maarten de Wit, et al.
The Lancet. Rheumatology|January 17, 2024
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Molla Huq, et al.
Pageof 12

Showing results (71-80 of 111) with videos related to

Sort By:
Pageof 12
Health and Quality of Life Outcomes|January 11, 2022
Development and measurement properties of the AxEL (attitude toward education and advice for low-back-pain) questionnaireEdel T O'Hagan, Ian W Skinner, Matthew D Jones, et al.
Biomacromolecules|July 30, 2019
Thermoresponsive Protein-Engineered Coiled-Coil Hydrogel for Sustained Small Molecule ReleaseLindsay K Hill, Michael Meleties, Priya Katyal, et al.
Development (Cambridge, England)|October 10, 2015
Aspm sustains postnatal cerebellar neurogenesis and medulloblastoma growth in miceScott E Williams, Idoia Garcia, Andrew J Crowther, et al.
Arthritis Research & Therapy|May 12, 2026
Clinical characteristics and response to standard-of-care treatment in systemic lupus erythematosus patients with or without anti-ribonucleoprotein (RNP) antibodies: an Australian, multi-centre cohort studyRangi Kandane-Rathnayake, Rachel Koelmeyer, Shereen Oon, et al.
Internal Medicine Journal|May 14, 2022
Australian recommendations on tapering of biologic and targeted synthetic disease-modifying anti-rheumatic drugs in inflammatory arthritisSamuel L Whittle, Vanessa Glennon, Renea V Johnston, et al.
BMJ Open|December 10, 2024
Integrating accelerometry, GPS, GIS and molecular data to investigate mechanistic pathways of the urban environmental exposome and cognitive outcomes in older adults: a longitudinal study protocolRuth F Hunter, Claire Cleland, Mike Trott, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
The Lancet. Rheumatology|January 23, 2024
Factors associated with damage accrual in patients with systemic lupus erythematosus with no clinical or serological disease activity: a multicentre cohort studyDiane Apostolopoulos, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Arthritis Care & Research|July 21, 2019
Patient and Caregiver Priorities for Medication Adherence in Gout, Osteoporosis, and Rheumatoid Arthritis: Nominal Group TechniqueAyano Kelly, Kathleen Tymms, Maarten de Wit, et al.
The Lancet. Rheumatology|January 17, 2024
Evaluation of remission definitions for systemic lupus erythematosus: a prospective cohort studyVera Golder, Rangi Kandane-Rathnayake, Molla Huq, et al.
Pageof 12